← FDA Drug Approvals (Drugs@FDA)

CANAGLIFLOZIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: APOTEX · Approved 2026-04-14

Drug application

FDA Application #

ANDA210449

Application type

Abbreviated New Drug Application (Generic)

Brand name

CANAGLIFLOZIN

Generic name

Canagliflozin

Active ingredients

CANAGLIFLOZIN

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

APOTEX

First approval

2026-04-14

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown